Clinical study results
In clinical studies,* MIEBO was shown to significantly reduce:
Signs of dry eye
Doctors saw improvements in the cornea, which is a protective layer covering the eye surface.
Symptoms of dry eye
People in the studies felt their eye dryness significantly improve.
MIEBO was also shown to improve the signs and symptoms of dry eye
In the studies, doctors checked the signs and symptoms of dry eye after 2 weeks, and again after 8 weeks. Patients saw significant improvement at both checkpoints.
*MIEBO was studied against saline in two clinical trials of more than 1200 patients who were treated four times per day.
Side effects with MIEBO are rare
MIEBO is a prescription eye drop approved by the FDA. Because it requires a prescription, it was studied in-depth in patients, unlike over-the-counter artificial tears.
More than 600 people were treated with MIEBO in 2 clinical studies lasting 57 days:
0 serious side effects
No one treated with MIEBO experienced serious side effects.
0.5% felt burning or stinging
Very few people reported burning or stinging when putting in MIEBO.
0.2% stopped using MIEBO due to side effects
Of the 614 people studied, only 1 person stopped using MIEBO because of side effects.
2.1% reported blurred vision
The most common side effect seen with MIEBO was blurred vision, which occurred in 2.1% of people. It usually resolved within minutes. 0.8% of people also experienced eye redness.
INDICATION
MIEBO® (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease.
IMPORTANT SAFETY INFORMATION
- Remove contact lenses before using MIEBO and wait for at least 30 minutes before reinserting
- It is important to use MIEBO exactly as prescribed
- It is not known if MIEBO is safe and effective in children under the age of 18
- The most common eye side effect seen in studies was blurred vision (1% to 3% of patients reported blurred vision and eye redness)
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information for MIEBO.
INDICATION
MIEBO® (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease.
IMPORTANT SAFETY INFORMATION
- Remove contact lenses before using MIEBO and wait for at least 30 minutes before reinserting
- It is important to use MIEBO exactly as prescribed
- It is not known if MIEBO is safe and effective in children under the age of 18
- The most common eye side effect seen in studies was blurred vision (1% to 3% of patients reported blurred vision and eye redness)
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full prescribing Information for MIEBO.
